Literature DB >> 8150014

The diagnosis of toxoplasmosis using IgG avidity.

R E Holliman1, R Raymond, N Renton, J D Johnson.   

Abstract

Current methods to establish the duration of toxoplasma infection in pregnant women and for the diagnosis of toxoplasmosis in the neonate or HIV infected patient have significant limitations. We assessed the precision of a commercial ELISA for the detection of toxoplasma specific IgG and adapted the assay to measure avidity using an elution agent washing step. The sensitivity and specificity of the ELISA were 100 and 75% respectively and optimal measurement of avidity was achieved using 6 M urea as the elution agent. Toxoplasma lymphadenopathy of less than 3 months duration was associated with low avidity specific IgG but some discordant findings were recorded. Serial measurement of IgG avidity assisted the distinction between actively produced antibody in infants with congenital toxoplasmosis and passively acquired antibody of maternal origin in uninfected babies. There was no significant difference between avidity levels in HIV infected patients with or without cerebral toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8150014      PMCID: PMC2271446          DOI: 10.1017/s0950268800057812

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  18 in total

1.  Direct agglutination test and other assays for measuring antibodies to Toxoplasma gondii.

Authors:  J Johnson; K Duffy; L New; R E Holliman; B S Chessum; D G Fleck
Journal:  J Clin Pathol       Date:  1989-05       Impact factor: 3.411

2.  Public Health Laboratory Service enzyme linked immunosorbent assay for detecting Toxoplasma specific IgM antibody.

Authors:  R A Payne; D H Joynson; A H Balfour; J P Harford; D G Fleck; M Mythen; R J Saunders
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Assessment of immunoglobulin-M immunosorbent agglutination assay (ISAGA) for detecting toxoplasma specific IgM.

Authors:  K T Duffy; P J Wharton; J D Johnson; L New; R E Holliman
Journal:  J Clin Pathol       Date:  1989-12       Impact factor: 3.411

5.  [Avidity of specific IgG antibodies as markers of recent primary infection caused by Toxoplasma gondii].

Authors:  M E Camargo; S M da Silva; P G Leser; C H Granato
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1991 May-Jun       Impact factor: 1.846

6.  Antibody avidity measurement and immune complex dissociation for serological diagnosis of vertically acquired HIV-1 infection.

Authors:  F Simon; C Rahimy; A Krivine; M Levine; J M Pepin; D Lapierre; E Denamur; L Vernoux; A De Crepy; P Blot
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-02

7.  Recent primary toxoplasma infection indicated by a low avidity of specific IgG.

Authors:  K Hedman; M Lappalainen; I Seppäiä; O Mäkelä
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

Review 8.  Toxoplasmosis and the acquired immune deficiency syndrome.

Authors:  R E Holliman
Journal:  J Infect       Date:  1988-03       Impact factor: 6.072

9.  Persistence of specific IgM and low avidity specific IgG1 following primary rubella.

Authors:  H I Thomas; P Morgan-Capner; G Enders; S O'Shea; D Caldicott; J M Best
Journal:  J Virol Methods       Date:  1992-09       Impact factor: 2.014

10.  Rubella-specific IgG subclass avidity ELISA and its role in the differentiation between primary rubella and rubella reinfection.

Authors:  H I Thomas; P Morgan-Capner
Journal:  Epidemiol Infect       Date:  1988-12       Impact factor: 2.451

View more
  18 in total

1.  Lack of utility of specific immunoglobulin G antibody avidity for serodiagnosis of reactivated toxoplasmosis in immunocompromised patients.

Authors:  B Mechain; Y J Garin; F Robert-Gangneux; J Dupouy-Camet; F Derouin
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

2.  Simplified assay for measuring Toxoplasma gondii immunoglobulin G avidity.

Authors:  H E Prince; M Wilson
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

3.  VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women.

Authors:  Jose G Montoya; Oliver Liesenfeld; Sandra Kinney; Cynthia Press; Jack S Remington
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

4.  Introduction to Measurement of Avidity of Anti-Coxiella burnetii IgG in Diagnosis of Q Fever.

Authors:  Léa Luciani; Coralie L'Ollivier; Matthieu Million; Bernard Amphoux; Sophie Edouard; Didier Raoult
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

5.  European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index.

Authors:  Eskild Petersen; Maria Victoria Borobio; Edward Guy; Oliver Liesenfeld; Valeria Meroni; Anne Naessens; Emma Spranzi; Philippe Thulliez
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

6.  Differentiation of primary from nonprimary genital herpes infections by a herpes simplex virus-specific immunoglobulin G avidity assay.

Authors:  M Hashido; S Inouye; T Kawana
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

7.  Immunoglobulin G avidity in diagnosis of toxoplasmic lymphadenopathy and ocular toxoplasmosis.

Authors:  M Paul
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

Review 8.  Delayed maturation of immunoglobulin G avidity: implication for the diagnosis of toxoplasmosis in pregnant women.

Authors:  M Lefevre-Pettazzoni; S Le Cam; M Wallon; F Peyron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-11       Impact factor: 3.267

9.  Identification, production and assessment of two Toxoplasma gondii recombinant proteins for use in a Toxoplasma IgG avidity assay.

Authors:  Ai Ying Teh; Atefeh Amerizadeh; Sabariah Osman; Muhammad Hafiznur Yunus; Rahmah Noordin
Journal:  Pathog Glob Health       Date:  2016-10-04       Impact factor: 2.894

10.  Spiramycin treatment of Toxoplasma gondii infection in pregnant women impairs the production and the avidity maturation of T. gondii-specific immunoglobulin G antibodies.

Authors:  V Meroni; F Genco; C Tinelli; P Lanzarini; L Bollani; M Stronati; E Petersen
Journal:  Clin Vaccine Immunol       Date:  2009-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.